KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $896.6 million.

  • Cme Group's Net Income towards Common Stockholders fell 0.52% to $896.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 8.61%. This contributed to the annual value of $3.5 billion for FY2024, which is 9.29% up from last year.
  • According to the latest figures from Q3 2025, Cme Group's Net Income towards Common Stockholders is $896.6 million, which was down 11.42% from $1.0 billion recorded in Q2 2025.
  • Cme Group's Net Income towards Common Stockholders' 5-year high stood at $1.0 billion during Q2 2025, with a 5-year trough of $510.3 million in Q2 2021.
  • Over the past 3 years, Cme Group's median Net Income towards Common Stockholders value was $872.1 million (recorded in 2024), while the average stood at $865.5 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 125.15% in 2021, then dropped by 27.57% in 2022.
  • Cme Group's Net Income towards Common Stockholders (Quarterly) stood at $605.9 million in 2021, then grew by 3.98% to $630.0 million in 2022, then grew by 27.67% to $804.3 million in 2023, then increased by 7.39% to $863.7 million in 2024, then declined by 0.52% to $896.6 million in 2025.
  • Its Net Income towards Common Stockholders was $896.6 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $944.2 million in Q1 2025.